20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Pulmonary Arterial Remodeling in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Adebesin, AM; Ali, S; Baruch, DE; Diegisser, D; Dirice, E; Falck, JR; Garcia, V; Kadish, Y; Kim, N; Kulaprathazhe, MM; Pascale, JV; Schwartzman, ML; Wolf, A; Yahaya, MAF; Yemane, D | 1 |
Bar, A; Chlopicki, S; Enggaard, C; Hansen, PBL; Jasztal, A; Jensen, B; Kieronska-Rudek, A; Kij, A; Marczyk, B; Mateuszuk, L; Matyjaszczyk-Gwarda, K; Proniewski, B; Przyborowski, K; Tworzydlo, A; Walczak, M | 1 |
Capdevila, JH; Dakarapu, R; Falck, JR; Gandham, SK; Garcia, V; Gilani, A; Graves, JP; Gruzdev, A; Pandey, V; Reddy, NR; Schwartzman, ML; Shkolnik, B; Zeldin, DC; Zhang, FF | 1 |
Booz, GW; Fan, F; He, X; Wang, S; Yu, Q; Zhang, C | 1 |
Rocic, P; Schwartzman, ML | 1 |
Fan, F; Geurts, AM; Jacob, HJ; Murphy, SR; Pabbidi, MR; Roman, RJ | 1 |
Edin, ML; Garcia, V; Hoopes, SL; Schwartzman, ML; Zeldin, DC | 1 |
Bernstein, KE; Capdevila, JH; Dakarapu, R; Ding, Y; Falck, JR; Garcia, V; Gotlinger, K; Joseph, G; Schwartzman, ML; Shkolnik, B; Zhang, FF | 1 |
3 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Pulmonary Arterial Remodeling
Article | Year |
---|---|
Conflicting roles of 20-HETE in hypertension and renal end organ damage.
Topics: Animals; Antihypertensive Agents; Arachidonic Acid; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Fibrosis; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, G-Protein-Coupled; Renal Elimination; Renal Insufficiency; Renin-Angiotensin System; Sodium; Vascular Remodeling | 2018 |
20-HETE in the regulation of vascular and cardiac function.
Topics: Animals; Cardiovascular Diseases; Endothelium, Vascular; ErbB Receptors; Humans; Hydroxyeicosatetraenoic Acids; Neovascularization, Pathologic; Neovascularization, Physiologic; Obesity; Receptors, G-Protein-Coupled; Signal Transduction; Vascular Remodeling | 2018 |
Vascular actions of 20-HETE.
Topics: Animals; Blood Vessels; Humans; Hydroxyeicosatetraenoic Acids; Neovascularization, Physiologic; Renin-Angiotensin System; Vascular Diseases; Vascular Remodeling | 2015 |
5 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Pulmonary Arterial Remodeling
Article | Year |
---|---|
20-Hydroxyeicosatetraenoic acid (20-HETE): Bioactions, receptors, vascular function, cardiometabolic disease and beyond.
Topics: Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Vascular Remodeling | 2023 |
Thrombin Inhibition Prevents Endothelial Dysfunction and Reverses 20-HETE Overproduction without Affecting Blood Pressure in Angiotensin II-Induced Hypertension in Mice.
Topics: Angiotensin II; Animals; Antithrombins; Chromatography, Liquid; Dabigatran; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypertension; Intercellular Adhesion Molecule-1; Male; Mice; Nitric Oxide; Tandem Mass Spectrometry; Vascular Remodeling; von Willebrand Factor | 2021 |
20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G
Topics: Animals; Cells, Cultured; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice; Mice, Transgenic; Protein Binding; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Vascular Remodeling | 2017 |
Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat.
Topics: Animals; Arterial Pressure; Blood-Brain Barrier; Capillary Permeability; Cerebrovascular Circulation; Cytochrome P-450 CYP4A; Disease Models, Animal; Genotype; Homeostasis; Hydroxyeicosatetraenoic Acids; Hypertension; Middle Cerebral Artery; Phenotype; Rats, Inbred Dahl; Rats, Inbred Lew; Rats, Transgenic; Sodium Chloride, Dietary; Transposases; Vascular Remodeling; Vasoconstriction | 2015 |
Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Female; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice, Transgenic; Microvessels; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Time Factors; Vascular Remodeling | 2015 |